Attending Physician of Jiangsu Provincial People’s Hospital, China
Dr. Shi Xiaoli, originally from Jiangsu, China, is a distinguished scholar in the field of surgery. π With a Ph.D. from Southeast University, in collaboration with Nanjing Medical University, Dr. Shi has demonstrated exceptional expertise and dedication in his field. π His academic journey includes a master’s degree in surgery from Nanjing Medical University, under the mentorship of esteemed advisors Wang Xuehao, Li Xiangcheng, and Yu Yue. π¨βπ«π©βπ« Currently residing in Gulou District, Nanjing, Dr. Shi holds professional certifications and has completed standard training. π π¨ββοΈ His contributions to the medical field are marked by a commitment to advancing surgical practices and knowledge.
Professional profile
Educationπ
Dr. Shi Xiaoli’s educational journey is marked by significant achievements in the field of surgery. π He pursued his doctoral studies at Southeast University, in collaboration with Nanjing Medical University, where he earned his Ph.D. in Surgery from September 2021 to July 2024. π Prior to this, he completed his Masterβs degree in Surgery at Nanjing Medical University from September 2018 to July 2021. π
Dr. Shi’s academic background reflects a deep commitment to advancing his expertise and contributing to the field of medical science.
Professional ExperienceποΈ
Dr. Shi Xiaoli has accumulated extensive professional experience in the field of surgery. πΌ His career is distinguished by significant contributions to medical practice and research, underscoring his expertise and dedication. π₯ With a robust foundation in clinical and academic settings, Dr. Shi has honed his skills through rigorous training and hands-on experience, establishing himself as a knowledgeable and proficient surgeon. π©Ί His professional journey reflects a strong commitment to enhancing patient care and advancing surgical techniques. π
Research Interestπ
Dr. Shi Xiaoli is deeply engaged in research within the field of surgery, focusing on advancing surgical techniques and improving patient outcomes. π¬ His interests span innovative surgical methods, disease treatment advancements, and the integration of cutting-edge technologies in medical practice. π₯π‘ Driven by a commitment to enhancing surgical precision and efficacy, Dr. Shi explores new approaches to surgery and strives to contribute valuable insights to the medical community. ππ His research aims to address current challenges in the field and push the boundaries of surgical science. π
Awards and Honorsπ
Dr. Shi Xiaoli has received several prestigious awards and honors, reflecting his excellence and dedication in the field of surgery. π His achievements include notable recognitions for outstanding research and contributions to medical science. π Among his accolades are esteemed awards from professional medical associations and institutions, highlighting his impact and leadership in the field. π
β¨ These honors not only celebrate his academic and clinical accomplishments but also underscore his commitment to advancing surgical practices and patient care. π₯π
Research skillπ¬
Dr. Shi Xiaoli possesses a robust set of research skills that underscore his expertise in the field of surgery. π¬ He excels in designing and conducting rigorous studies, utilizing advanced methodologies to explore surgical techniques and patient care innovations. π With a keen eye for detail and a commitment to precision, Dr. Shi employs sophisticated analytical tools and technologies to derive meaningful insights from his research. π‘ His ability to critically evaluate data and integrate findings into practical applications reflects his deep understanding of both clinical and academic aspects of surgery. π₯π His research skills contribute significantly to advancing medical science and improving surgical outcomes. ππ
Achievementsπ
- π Ph.D. in Surgery from Southeast University (Jointly trained with Nanjing Medical University)
- π
Masterβs Degree in Surgery from Nanjing Medical University
- π©Ί Professional Certification in Surgery
- π¨ββοΈ Completed Standard Training in clinical practice
- π Significant Contributions to surgical techniques and patient care innovations
- π¬ Advanced Research in surgical methods and technologies
Projectsπ οΈ
- π₯ Innovative Surgical Techniques: Development and implementation of new methods to improve surgical outcomes.
- π¬ Advanced Research Studies: Exploration of cutting-edge technologies and approaches in surgery.
- π Patient Care Enhancements: Projects focused on optimizing patient care through improved surgical practices.
- π‘ Technology Integration: Incorporation of advanced technologies into surgical procedures and treatment plans.
- π§ͺ Clinical Trials: Conducting trials to assess the efficacy and safety of new surgical techniques and treatments.
Publicationπ
- RAC1^high NK cell-based immunotherapy in hepatocellular carcinoma via STAT3-NKG2D axis
- π Authors: Shi, X., Chen, W., Yin, Y., Yu, Y., Wang, X.
- π
Year: 2024
- ποΈ Journal: Cancer Letters
- π Citations: 0
- Cuproptosis-associated genes (CAGs) contribute to the prognosis prediction and potential therapeutic targets in hepatocellular carcinoma
- π Authors: Shi, X., Shi, D., Yin, Y., Yu, Y., Wang, X.
- π
Year: 2024
- ποΈ Journal: Cellular Signalling
- π Citations: 0
- MAD2 activates IGF1R/PI3K/AKT pathway and promotes cholangiocarcinoma progression by interfering USP44/LIMA1 complex
- π Authors: Jiang, W., Yang, X., Shi, K., Li, C., Li, X.
- π
Year: 2023
- ποΈ Journal: Oncogene
- π Citations: 3
- Thymidine kinase 1 drives hepatocellular carcinoma in enzyme-dependent and -independent manners
- π Authors: Li, Q., Zhang, L., Yang, Q., Zhang, P., Wang, X.
- π
Year: 2023
- ποΈ Journal: Cell Metabolism
- π Citations: 10
- KIF14 promotes proliferation, lymphatic metastasis and chemoresistance through G3BP1/YBX1 mediated NF-ΞΊB pathway in cholangiocarcinoma
- π Authors: Jiang, W., Wang, J., Yang, X., Li, C., Li, X.
- π
Year: 2023
- ποΈ Journal: Oncogene
- π Citations: 8
- Exosomal lncRNA HCG18 contributes to cholangiocarcinoma growth and metastasis through mediating miR-424-5p/SOX9 axis through PI3K/AKT pathway
- π Authors: Ni, Q., Zhang, H., Shi, X., Li, X.
- π
Year: 2023
- ποΈ Journal: Cancer Gene Therapy
- π Citations: 13
- Exosomal miR-30a-5p promoted intrahepatic cholangiocarcinoma progression by increasing angiogenesis and vascular permeability in PDCD10 dependent manner
- π Authors: Jiang, W., Shi, X., Sun, L., Li, C., Li, X.
- π
Year: 2023
- ποΈ Journal: International Journal of Biological Sciences
- π Citations: 1
- NUF2 Drives Cholangiocarcinoma Progression and Migration via Inhibiting Autophagic Degradation of TFR1
- π Authors: Shan, J., Jiang, W., Chang, J., Li, C., Li, X.
- π
Year: 2023
- ποΈ Journal: International Journal of Biological Sciences
- π Citations: 6
- CircPAK1 promotes the progression of hepatocellular carcinoma via modulation of YAP nucleus localization by interacting with 14-3-3ΞΆ
- π Authors: Hao, X., Zhang, Y., Shi, X., Tang, W., Wang, X.
- π
Year: 2022
- ποΈ Journal: Journal of Experimental and Clinical Cancer Research
- π Citations: 32
- ROBO1 p.E280 Loses the Inhibitory Effects on the Proliferation and Angiogenesis of Wild-Type ROBO1 in Cholangiocarcinoma by Interrupting SLIT2 Signal*
- π Authors: Zhou, T., Zhang, Y., Chen, Y., Li, C., Li, X.
- π
Year: 2022
- ποΈ Journal: Frontiers in Oncology
- π Citations: 2
